Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Maize breeder rewarded for his research to enhance food security in Africa
2016-08-26

Description: Maize breeder rewarded  Tags: Maize breeder rewarded

Prof Maryke Labuschagne from the UFS Department
of Plant Sciences, Berhanu Tadesse Ertiro, a
postgraduate student in Plant breeding at the UFS,
and Dr Peg Redinbaugh of the US Department of
Agriculture in Wooster, Ohio.
Photo: Supplied

Ethiopia is one of the African countries, deeply affected by food insecurity. Berhanu Tadesse Ertiro, a citizen from Ethiopia started his career - after graduating with his undergraduate degree in 2003 - as a junior maize breeder. Today he is pursuing his doctorate degree in Plant Breeding at the University of the Free State (UFS).

His research had made some great strides in contributing to food security in Africa. He recently received a fellowship from the prestigious Norman E. Borlaug Leadership Enhancement in Agriculture Program (Borlaug LEAP).

This fellowship is only awarded to students whose research has relevance to the national development of the student’s home country or region. The aim of these fellowships are to enhance the quality of thesis research of graduate students from developing countries who show strong promise as leaders in the field of agriculture and related disciplines.

Low soil fertility a major maize production constraint
Berhanu is also a visiting student at the International Maize and Wheat Improvement Center (CIMMYT) in Kenya, where he is running field experiments for his PhD thesis dissertation. His research focuses on Nitrogen Use Efficiency (NUE) and Maize Lethal Necrosis (MLN) disease tolerance. Low soil fertility and MLN are among the major maize production constraints in eastern and southern Africa, where maize is staple food.

Such hybrids have the potential to contribute greatly
towards food security among farmers and their
families through increased productivity.

The use of new tools could increase breeding efficiency and reduce the time needed for the release of new stress tolerant hybrids. Such hybrids have the potential to contribute greatly towards food security among farmers and their families through increased productivity. Berhanu is looking at the feasibility of genome wide selection for improvement of NUE in tropical maize.

Fellowship includes mentorship and supervision across borders
The programme supports engaging a mentor at a United States university and Consortium of International Agricultural Research Centers (CGIAR). During his fellowship, he will be supervised and mentored by Prof Maryke Labuschagne of the UFS, Prof Rex Bernando, a professor of Corn Breeding and Genetics at the University of Minnesota and Dr Biswanath Das of CIMMYT, Kenya.

As a LEAP fellow, Berhanu was invited to attend the 30th Annual World Food Prize events to take place in October 2016, in Des Moines, Iowa. The week will include his attendance at the Board for International Food and Agricultural Development meeting, participation at side-events at the Borlaug Dialogue International Symposium and the World Food Prize.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept